Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6603789 | 1.00 | PPARG (0.54) | PPARGPPARA | |
| SCHEMBL6603784 | 1.00 | PPARG (0.54) | PPARGPPARA | |
| SCHEMBL27568045 | 0.93 | PPARG (0.55) | PPARGPPARA | |
| SCHEMBL6606538 | 0.93 | PPARG (0.55) | PPARGPPARA | |
| SCHEMBL6607023 | 0.93 | PPARG (0.55) | PPARGPPARA | |
| SCHEMBL6607035 | 0.93 | PPARG (0.55) | PPARGPPARA | |
| SCHEMBL6603119 | 0.90 | PPARG (0.52) | PPARGPPARA | |
| SCHEMBL6603125 | 0.90 | PPARG (0.52) | PPARGPPARA | |
| SCHEMBL6603112 | 0.90 | PPARG (0.52) | PPARGPPARA | |
| SCHEMBL6605839 | 0.87 | PPARG (0.63) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6498174-B1 | AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME | SMITHKLINE BEECHAM CORPORATION | 2002-12-24 | — | — | US | claimed |
| EP-1102757-B1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LTD (GB) | 2004-04-14 | — | — | EP | disclosed |
| US-6498174-B1 | AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME | SMITHKLINE BEECHAM CORPORATION | 2002-12-24 | — | — | US | disclosed |